| Pharmaceutical active ingredients: |
| Niflumic Acid |
| Available forms, composition and doses of Forenol: |
| N / A |
| Forenol medical category: |
| Human:Cyclooxygenase-2 inhibitorsJoint and muscular pain treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX02 - Niflumic AcidM02AA17 - Niflumic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fontamide | Sulfathiourea | Unidentified Pharmaceutical Company |
| Fontiliz | Meticrane | Unidentified Pharmaceutical Company |
| Fonurit | Acetazolamide | Unidentified Pharmaceutical Company |
| Force | Tefluthrin | Unidentified Pharmaceutical Company |
| Fordor | Formaldehyde | Unidentified Pharmaceutical Company |
| Forhistal | Dimethindene | Unidentified Pharmaceutical Company |
| Forlin | Lindane | Unidentified Pharmaceutical Company |
| Formagene | Formaldehyde | Unidentified Pharmaceutical Company |
| Formal | Malathion | Unidentified Pharmaceutical Company |
| Formalith | Formaldehyde | Unidentified Pharmaceutical Company |